GeneDx Holdings (WGS) Misses Q4 EPS by 70c ; Offers Guidance

GeneDx Holdings (NASDAQ: WGS) reported Q4 EPS of ($0.61), $0.70 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $121 million versus the consensus estimate of $120.55 million.

GUIDANCE:

GeneDx Holdings sees FY2026 revenue of $540-555 million, versus the consensus of $543 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• ZenaTech raises Plurilock Security stake to 12% with new share purchase